|
1
|
Khan R and Sheppard R: Fibrosis in heart
disease: Understanding the role of transforming growth factor-beta
in cardiomyopathy, valvular disease and arrhythmia. Immunology.
118:10–24. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Camelliti P, Borg TK and Kohl P:
Structural and functional characterisation of cardiac fibroblasts.
Cardiovasc Res. 65:40–51. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Krenning G, Zeisberg EM and Kalluri R: The
origin of fibroblasts and mechanism of cardiac fibrosis. J Cell
Physiol. 225:631–637. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee AA, Dillmann WH, McCulloch AD and
Villarreal FJ: Angiotensin II stimulates the autocrine production
of transforming growth factor-beta 1 in adult rat cardiac
fibroblasts. J Mol Cell cardiol. 27:2347–2357. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lim DS, Lutucuta S, Bachireddy P, Youker
K, Evans A, Entman M, Roberts R and Marian AJ: Angiotensin II
blockade reverses myocardial fibrosis in a transgenic mouse model
of human hypertrophic cardiomyopathy. Circulation. 103:789–791.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kawano H, Do YS, Kawano Y, Starnes V, Barr
M, Law RE and Hsueh WA: Angiotensin II has multiple profibrotic
effects in human cardiac fibroblasts. Circulation. 101:1130–1137.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hara M, Sakata Y, Nakatani D, Suna S,
Usami M, Matsumoto S, Sugitani T, Ozaki K, Nishino M, Sato H, et
al: Renin-angiotensin-aldosterone system polymorphisms and 5-year
mortality in survivors of acute myocardial infarction: A report
from the osaka acute coronary insufficiency study. Int Heart J.
55:190–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mehta PK and Griendling KK: Angiotensin II
cell signaling: Physiological and pathological effects in the
cardiovascular system. Am J Physiol Cell Physiol. 292:C82–C97.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hirai S, Uemura T, Mizoguchi N, Lee JY,
Taketani K, Nakano Y, Hoshino S, Tsuge N, Narukami T, Yu R, et al:
Diosgenin attenuates inflammatory changes in the interaction
between adipocytes and macrophages. Mol Nutr Food Res. 54:797–804.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park HJ, Byeon HE, Koo HJ and Pyo S:
Anti-atherosclerotic effects of diosgenin in ApoE-deficient mice.
FASEB J. 25:980–982. 2011.
|
|
11
|
Moalic S, Liagre B, Corbière C, Bianchi A,
Dauça M, Bordji K and Beneytout JL: A plant steroid, diosgenin,
induces apoptosis, cell cycle arrest and COX activity in
osteosarcoma cells. FEBS Lett. 506:225–230. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Son IS, Kim JH, Sohn HY, Son KH, Kim JS
and Kwon CS: Antioxidative and hypolipidemic effects of diosgenin,
a steroidal saponin of yam (Dioscorea spp.), on high-cholesterol
fed rats. Biosci Biotech Biochem. 71:3063–3071. 2007. View Article : Google Scholar
|
|
13
|
Badalzadeh R, Yousefi B, Tajaddini A and
Ahmadian N: Diosgenin-induced protection against myocardial
ischaemia-reperfusion injury is mediated by mitochondrial KATP
channels in a rat model. Perfusion. 30:565–571. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang WC, Liu SF, Chang WT, Shiue YL, Hsieh
PF, Hung TJ, Hung CY, Hung YJ, Chen MF and Yang YL: The effects of
diosgenin in the Regulation of renal proximal tubular fibrosis. Exp
Cell Res. 323:255–262. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Quintas LE, Pierre SV, Liu L, Bai Y, Liu X
and Xie ZJ: Alterations of Na+/K+-ATPase function in caveolin-1
knockout cardiac fibroblasts. J Mol Cell Cardiol. 49:525–531. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schnee JM and Hsueh WA: Angiotensin II,
adhesion, and cardiac fibrosis. Cardiovasc Res. 46:264–268. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bouzegrhane F and Thibault G: Is
angiotensin II a proliferative factor of cardiac fibroblasts?
Cardiovasc Res. 53:304–312. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Van Kesteren CA, Van Heugten HA, Lamers
JM, Saxena PR, Schalekamp MA and Danser AH: Angiotensin II-mediated
growth and antigrowth effects in cultured neonatal rat cardiac
myocytes and fibroblasts. J Mol Cell Cardiol. 29:2147–2157. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hattori Y, Hattori S, Akimoto K, Nishikimi
T, Suzuki K, Matsuoka H and Kasai K: Globular adiponectin activates
nuclear factor-kappaB and activating protein-1 and enhances
angiotensin II-induced proliferation in cardiac fibroblasts.
Diabetes. 56:804–808. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roy S, Khanna S, Rink T, Radtke J,
Williams WT, Biswas S, Schnitt R, Strauch AR and Sen CK:
P21waf1/cip1/sdi1 as a central regulator of inducible smooth muscle
actin expression and differentiation of cardiac fibroblasts to
myofibroblasts. Mol Biol Cell. 18:4837–4846. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu M, Han M, Li J, Xu X, Li T, Que L, Ha
T, Li C, Chen Q and Li Y: 17beta-estradiol inhibits angiotensin
II-induced cardiac myofibroblast differentiation. Eur J Pharmacol.
616:155–159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cucoranu I, Clempus R, Dikalova A, Phelan
PJ, Ariyan S, Dikalov S and Sorescu D: NAD(P)H oxidase 4 mediates
transforming growth factor-beta1-induced differentiation of cardiac
fibroblasts into myofibroblasts. Circ Res. 97:900–907. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Leask A: Potential therapeutic targets for
cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF,
partners in fibroblast activation. Circ Res. 106:1675–1680. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reddy VS, Harskamp RE, Van Ginkel MW,
Calhoon J, Baisden CE, Kim IS, Valente AJ and Chandrasekar B:
Interleukin-18 stimulates fibronectin expression in primary human
cardiac fibroblasts via PI3K-Akt-dependent NF-kappaB activation. J
Cell Physiol. 215:697–707. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brilla CG, Zhou G, Matsubara L and Weber
KT: Collagen metabolism in cultured adult rat cardiac fibroblasts:
Response to angiotensin II and aldosterone. J Mol Cell cardiol.
26:809–820. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brilla CG, Zhou G, Rupp H, Maisch B and
Weber KT: Role of angiotensin II and prostaglandin E2 in regulating
cardiac fibroblast collagen turnover. Am J Cardiol. 76:8D–13D.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen K, Chen J, Li D, Zhang X and Mehta
JL: Angiotensin II regulation of collagen type I expression in
cardiac fibroblasts: Modulation by PPAR-gamma ligand pioglitazone.
Hypertension. 44:655–661. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li P, Wang D, Lucas J, Oparil S, Xing D,
Cao X, Novak L, Renfrow MB and Chen YF: Atrial natriuretic peptide
inhibits transforming growth factor beta-induced smad signaling and
myofibroblast transformation in mouse cardiac fibroblasts. Circ
Res. 102:185–192. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yan W, Wang P, Zhao CX, Tang J, Xiao X and
Wang DW: Decorin gene delivery inhibits cardiac fibrosis in
spontaneously hypertensive rats by modulation of transforming
growth factor-beta/Smad and p38 mitogen-activated protein kinase
signaling pathways. Hum Gene ther. 20:1190–1200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu X, Sun SQ, Hassid A and Ostrom RS:
cAMP inhibits transforming growth factor-beta-stimulated collagen
synthesis via inhibition of extracellular signal-regulated kinase
1/2 and Smad signaling in cardiac fibroblasts. Mol Pharmacol.
70:1992–2003. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shi Y and Massagué J: Mechanisms of
TGF-beta signaling from cell membrane to the nucleus. Cell.
113:685–700. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen K, Mehta JL, Li D, Joseph L and
Joseph J: Transforming growth factor beta receptor endoglin is
expressed in cardiac fibroblasts and modulates profibrogenic
actions of angiotensin II. Circ Res. 95:1167–1173. 2004. View Article : Google Scholar : PubMed/NCBI
|
